Treatment with C1-inhibitor concentrate does not induce IgM type anti-C1 inhibitor antibodies in patients with hereditary angioedema
- 31 January 2011
- journal article
- Published by Elsevier in Molecular Immunology
- Vol. 48 (4), 572-576
- https://doi.org/10.1016/j.molimm.2010.10.012
Abstract
No abstract availableKeywords
This publication has 28 references indexed in Scilit:
- C1-inhibitor autoantibodies in SLELupus, 2010
- C1-inhibitor deficiency and angioedema: molecular mechanisms and clinical progressTrends in Molecular Medicine, 2009
- Treatment of skin swellings with C1‐inhibitor concentrate in patients with hereditary angio‐oedemaAllergy, 2008
- The use of plasma-derived C1 inhibitor in the treatment of hereditary angioedemaExpert Opinion on Pharmacotherapy, 2007
- C1-inhibitor (C1-INH) autoantibodies in hereditary angioedema: Strong correlation with the severity of disease in C1-INH concentrate naïve patientsMolecular Immunology, 2007
- Treatment with C1 inhibitor concentrate in abdominal pain attacks of patients with hereditary angioedemaTransfusion, 2005
- The critical concentration of C1-esterase inhibitor (C1-INH) in human serum preventing auto-activation of the first component of complement (C1)Molecular Immunology, 2005
- Hereditary and acquired angioedema: Problems and progress: Proceedings of the third C1 esterase inhibitor deficiency workshop and beyondJournal of Allergy and Clinical Immunology, 2004
- Autoantibodies and Lymphoproliferative Diseases in Acquired C1-Inhibitor DeficienciesMedicine, 2003
- Studies of complement autoactivatability in hereditary angioedema: Direct relationship to functional -INA and the effect of classical pathway activatorsClinical Immunology and Immunopathology, 1984